Jaldeep Daulat, DO
MOHS-Micrographic Surgery · Las Vegas, NVNPI 1114949492
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,720 of the $2,077 with a category attached, or 82.8%. 15 manufacturers reported payments, led by AbbVie at 35.6% of the total.
Across 97 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$739
- Johnson & Johnson$536
- Amgen$271
- UCB, Inc.$118
- Novartis$82
- Boston Scientific$65
- plus $267 from 9 others
What the payments were for
- Food & beverage$1,72083%
- Education$35717%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $739 |
| Johnson & Johnson | 17 | $536 |
| Amgen | 13 | $271 |
| UCB, Inc. | 4 | $118 |
| Novartis | 4 | $82 |
| Boston Scientific | 4 | $65 |
| E.r. Squibb & Sons, L.L.C. | 4 | $59 |
| Smith+Nephew | 1 | $43 |
| Organon | 2 | $40 |
| Lilly USA, LLC | 2 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Pfizer | 1 | $20 |
| Organogenesis Inc. | 1 | $18 |
| LEO Pharma Inc. | 1 | $17 |
| Biofrontera Inc. | 2 | $14 |
How this compares
Too few mohs-micrographic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 527 | $4,051 |
| Doxycycline Hyclate | 335 | $1,608 |
| Fluocinonide | 22 | $1,031 |
| Cephalexin | 186 | $900 |
| Clobetasol Propionate | 11 | $871 |
| Triamcinolone Acetonide | 63 | $758 |
| Betamethasone Dipropionate | 12 | $651 |
| Ketoconazole | 28 | $521 |
| Doxycycline Monohydrate | 35 | $200 |
| Hydroxyzine Hcl | 23 | $160 |
| Azithromycin | 31 | $128 |
| Terbinafine Hcl | 13 | $89 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Las Vegas
- James del RossoLas Vegas$3.6M
- Lucius BlanchardLas Vegas$14K
- Grace KimLas Vegas$10K
- Mac MachanLas Vegas$8K
- Douglas ThomasLas Vegas$3K
- Maria Sarah BovenbergLas Vegas$434
- Judy DoongReno$7K
- Whitney CallHenderson$3K
- Ruth AdamsCarson City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.